Table of Contents

1 Industry Overview

• 1.1 Ophthalmology Drugs Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Ophthalmology Drugs
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Ophthalmology Drugs Market by Type

• 3.1 By Type
  • 3.1.1 Lucentis (ranibizumab)
  • 3.1.2 Eylea (aflibercept)
  • 3.1.3 Avastin (bevacizumab)
  • 3.1.4 Restasis (cyclosporine)
  • 3.1.5 Alphagan (brimonidine tartrate)
  • 3.1.6 Lumigan (bimatoprost)
  • 3.1.7 Xalatan (latanoprost
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.Ophthalmology Drugs Novartis (Company Profile, Sales Data etc.)

• 4.2 Regeneron (Company Profile, Sales Data etc.)
• 4.3 Roche (Company Profile, Sales Data etc.)
• 4.4 Bayer (Company Profile, Sales Data etc.)
• 4.5 Allergan (Company Profile, Sales Data etc.)
• 4.6 Shire (Company Profile, Sales Data etc.)
• 4.7 Mallinckrodt (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Chorioretinitis
  • 6.1.2 Demand in Choroiditis
  • 6.1.3 Demand in Retinitis
  • 6.1.4 Demand in Others
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Ophthalmology Drugs

Table Application Segment of Ophthalmology Drugs

Table Global Ophthalmology Drugs Market 2013-2024, by Application, in USD Million

Table Major Company List of Lucentis (ranibizumab)

Table Major Company List of Eylea (aflibercept)

Table Major Company List of Avastin (bevacizumab)

Table Major Company List of Restasis (cyclosporine)

Table Major Company List of Alphagan (brimonidine tartrate)

Table Major Company List of Lumigan (bimatoprost)

Table Major Company List of Xalatan (latanoprost

Table Global Ophthalmology Drugs Market 2013-2018, by Type, in USD Million

Table Global Ophthalmology Drugs Market 2013-2018, by Type, in Volume

Table Global Ophthalmology Drugs Market Forecast 2019-2024, by Type, in USD Million

Table Global Ophthalmology Drugs Market Forecast 2019-2024, by Type, in Volume

Table Novartis Overview List

Table Ophthalmology Drugs Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Regeneron Overview List

Table Ophthalmology Drugs Business Operation of Regeneron (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Roche Overview List

Table Ophthalmology Drugs Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bayer Overview List

Table Ophthalmology Drugs Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Allergan Overview List

Table Ophthalmology Drugs Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Shire Overview List

Table Ophthalmology Drugs Business Operation of Shire (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Mallinckrodt Overview List

Table Ophthalmology Drugs Business Operation of Mallinckrodt (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Ophthalmology Drugs Sales Revenue 2013-2018, by Company, in USD Million

Table Global Ophthalmology Drugs Sales Revenue Share, by Company, in USD Million

Table Global Ophthalmology Drugs Sales Volume 2013-2018, by Company, in Volume

Table Global Ophthalmology Drugs Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Ophthalmology Drugs Demand Forecast 2019-2024, by Application, in USD Million

Table Ophthalmology Drugs Demand Forecast 2019-2024, by Application, in Volume

Table Ophthalmology Drugs Production 2013-2018, by Region, in USD Million

Table Ophthalmology Drugs Production 2013-2018, by Region, in Volume

Table Global Ophthalmology Drugs Market 2013-2018, by Region, in USD Million

Table Global Ophthalmology Drugs Market Share 2013-2018, by Region, in USD Million

Table Global Ophthalmology Drugs Market 2013-2018, by Region, in Volume

Table Global Ophthalmology Drugs Market Share 2013-2018, by Region, in Volume

Table North America Ophthalmology Drugs Market Size 2013-2018, by Country, in USD Million

Table North America Ophthalmology Drugs Market Size 2013-2018, by Country, in Volume

Table Europe Ophthalmology Drugs Market Size 2013-2018, by Country, in USD Million

Table Europe Ophthalmology Drugs Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Ophthalmology Drugs Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Ophthalmology Drugs Market Size 2013-2018, by Country, in Volume

Table South America Ophthalmology Drugs Market Size 2013-2018, by Country, in USD Million

Table South America Ophthalmology Drugs Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Ophthalmology Drugs Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Ophthalmology Drugs Market Size 2013-2018, by Country, in Volume

Table Ophthalmology Drugs Market Forecast 2019-2024, by Region, in USD Million

Table Ophthalmology Drugs Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Ophthalmology Drugs Market Growth 2013-2018, by Type, in USD Million

Figure Global Ophthalmology Drugs Market Growth 2013-2018, by Type, in Volume

Figure North America Ophthalmology Drugs Market Concentration, in 2018

Figure Europe Ophthalmology Drugs Market Market Concentration, in 2018

Figure Asia-Pacific Ophthalmology Drugs MMarket Concentration, in 2018

Figure South America Ophthalmology Drugs Market Concentration, in 2018

Figure Middle East & Africa Ophthalmology Drugs Market Concentration, in 2018

Figure Ophthalmology Drugs Demand in Chorioretinitis, 2013-2018, in USD Million

Figure Ophthalmology Drugs Demand in Chorioretinitis, 2013-2018, in Volume

Figure Ophthalmology Drugs Demand in Choroiditis, 2013-2018, in USD Million

Figure Ophthalmology Drugs Demand in Choroiditis, 2013-2018, in Volume

Figure Ophthalmology Drugs Demand in Retinitis, 2013-2018, in USD Million

Figure Ophthalmology Drugs Demand in Retinitis, 2013-2018, in Volume

Figure Ophthalmology Drugs Demand in Others, 2013-2018, in USD Million

Figure Ophthalmology Drugs Demand in Others, 2013-2018, in Volume

Figure North America Ophthalmology Drugs Market Size and Growth 2013-2018, in USD Million

Figure North America Ophthalmology Drugs Market Size and Growth 2013-2018, in Volume

Figure Europe Ophthalmology Drugs Market Size and Growth 2013-2018, in USD Million

Figure Europe Ophthalmology Drugs Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Ophthalmology Drugs Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Ophthalmology Drugs Market Size and Growth 2013-2018, in Volume

Figure South America Ophthalmology Drugs Market Size and Growth 2013-2018, in USD Million

Figure South America Ophthalmology Drugs Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Ophthalmology Drugs Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Ophthalmology Drugs Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview

Snapshot
The global Ophthalmology Drugs market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Ophthalmology Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Lucentis (ranibizumab)
Eylea (aflibercept)
Avastin (bevacizumab)
Restasis (cyclosporine)
Alphagan (brimonidine tartrate)
Lumigan (bimatoprost)
Xalatan (latanoprost
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Novartis
Regeneron
Roche
Bayer
Allergan
Shire
Mallinckrodt
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Chorioretinitis
Choroiditis
Retinitis
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)